These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30254295)

  • 1. Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells.
    He P; Qiu K; Jia Y
    Sci Rep; 2018 Sep; 8(1):14323. PubMed ID: 30254295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination.
    Lu M; Jolly MK; Levine H; Onuchic JN; Ben-Jacob E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18144-9. PubMed ID: 24154725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
    Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
    Front Oncol; 2020; 10():553342. PubMed ID: 33014880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
    Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
    Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial Cooperativity in miR200-Zeb Feedback Network can Control Epithelial-Mesenchymal Transition.
    Rashid M; Devi BM; Banerjee M
    Bull Math Biol; 2024 Mar; 86(5):48. PubMed ID: 38555331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
    Cho ES; Kang HE; Kim NH; Yook JI
    Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
    Liao TT; Yang MH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.
    Spaderna S; Schmalhofer O; Hlubek F; Jung A; Kirchner T; Brabletz T
    Verh Dtsch Ges Pathol; 2007; 91():21-8. PubMed ID: 18314592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiverse nature of epithelial to mesenchymal transition.
    Simeone P; Trerotola M; Franck J; Cardon T; Marchisio M; Fournier I; Salzet M; Maffia M; Vergara D
    Semin Cancer Biol; 2019 Oct; 58():1-10. PubMed ID: 30453041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?
    Sannino G; Marchetto A; Kirchner T; Grünewald TGP
    Cancer Res; 2017 Sep; 77(17):4556-4561. PubMed ID: 28811330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
    Sinha D; Saha P; Samanta A; Bishayee A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis.
    Huang B; Jolly MK; Lu M; Tsarfaty I; Ben-Jacob E; Onuchic JN
    Sci Rep; 2015 Dec; 5():17379. PubMed ID: 26627083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT and MET: necessary or permissive for metastasis?
    Jolly MK; Ware KE; Gilja S; Somarelli JA; Levine H
    Mol Oncol; 2017 Jul; 11(7):755-769. PubMed ID: 28548345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
    Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
    Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient?
    Krasnapolski MA; Todaro LB; de Kier Joffé EB
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1891-9. PubMed ID: 21470129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transitions in development and pathologies.
    Thiery JP
    Curr Opin Cell Biol; 2003 Dec; 15(6):740-6. PubMed ID: 14644200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.